HomeABCL • NASDAQ
add
AbCellera Biologics Inc
$4.47
Makalipas ang Oras ng Trabaho:(1.34%)+0.060
$4.53
Sarado: Set 12, 7:56:12 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$4.61
Sakop ng araw
$4.45 - $4.70
Sakop ng taon
$1.89 - $5.82
Market cap
1.34B USD
Average na Volume
4.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 17.08M | 133.29% |
Gastos sa pagpapatakbo | 27.46M | -54.13% |
Net na kita | -34.73M | 5.97% |
Net profit margin | -203.27 | 59.69% |
Kita sa bawat share | -0.12 | 7.69% |
EBITDA | -44.11M | 22.51% |
Aktuwal na % ng binabayarang buwis | 4.45% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 553.08M | -17.49% |
Kabuuang asset | 1.40B | -0.74% |
Kabuuang sagutin | 394.98M | 31.00% |
Kabuuang equity | 1.01B | — |
Natitirang share | 298.83M | — |
Presyo para makapag-book | 1.35 | — |
Return on assets | -9.03% | — |
Return on capital | -11.07% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -34.73M | 5.97% |
Cash mula sa mga operasyon | -32.40M | -8.14% |
Cash mula sa pag-invest | -31.81M | -161.06% |
Cash mula sa financing | -3.38M | -227.31% |
Net change in cash | -66.83M | -370.13% |
Malayang cash flow | -61.07M | -43.54% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
596
